Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.
about
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus ErythematosusDialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease.Antiphospholipid Antibodies in Lupus Nephritis.Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery StudyTargeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.Novel biomarkers for systemic lupus erythematosus.
P2860
Q26782454-AE820B01-37EC-4CFC-AFAC-9853281C2372Q35280905-4DE82B49-6022-46BD-8154-100F1C8A4BB5Q36060060-BB29F458-C1C9-499F-B7B5-9268302E8990Q37541229-C564AFC6-4E63-4A2A-A205-5A414093A049Q38755707-B4F8FE43-A1E6-4D15-831B-AA90B7B2E2D2Q39101016-6FF01796-BB25-407C-BF21-925DF5E505B3Q47676874-F8F8963A-8075-4017-BD8F-58C56631AAB8Q51349898-DDE7F53E-0588-4381-B821-B2DAD4E7354EQ52552445-FF5E3CDA-6173-43C0-8FFD-A106ACC2553D
P2860
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evaluation of B lymphocyte sti ...... e following induction therapy.
@ast
Evaluation of B lymphocyte sti ...... e following induction therapy.
@en
type
label
Evaluation of B lymphocyte sti ...... e following induction therapy.
@ast
Evaluation of B lymphocyte sti ...... e following induction therapy.
@en
prefLabel
Evaluation of B lymphocyte sti ...... e following induction therapy.
@ast
Evaluation of B lymphocyte sti ...... e following induction therapy.
@en
P2093
P2860
P50
P1476
Evaluation of B lymphocyte sti ...... e following induction therapy.
@en
P2093
Agneta Zickert
Birgitta Sundelin
Iva Gunnarsson
Jakob Gerhardsson
Magnus Axelsson
P2860
P304
P356
10.1136/LUPUS-2014-000061
P577
2015-01-22T00:00:00Z